AstraZeneca

GSK told to pay higher royalties to AZ on Zejula sales
Pharmaphorum
Thu, 04/6/23 - 11:37 am
GSK
AstraZeneca
ovarian cancer
Zejula
legal
UK
Biopharma stocks go back to bleak
EP Vantage
Thu, 04/6/23 - 09:51 am
Albireo Pharma
Amryt Pharma
Apellis Pharmaceuticals
AstraZeneca
BridgeBio
Novo Nordisk
Pfizer
Protagonist Therapeutics
Provention Bio
Reata Pharmaceuticals
Regeneron
Sanofi
Seagen
AstraZeneca's Lynparza-Imfinzi combo clears PhIII trial in ovarian cancer
Endpoints
Wed, 04/5/23 - 10:14 am
AstraZeneca
Lynparza
Imfinzi
ovarian cancer
clinical trials
Reeling from AstraZeneca's termination of pneumonia collab, Aridis lays off 20% of staff
Fierce Biotech
Mon, 04/3/23 - 10:14 am
AstraZeneca
Aridis Pharmaceuticals
MedImmune
monoclonal antibodies
suvratoxumab
layoffs
Go or no go? Seagen's Padcev eyes FDA approval
EP Vantage
Mon, 04/3/23 - 09:41 am
FDA
AbbVie
Alvotech
Ascendis Pharma
Astellas
AstraZeneca
Biogen
Daiichi Sankyo
Eli Lilly
Ferring Pharmaceuticals
Hugel
Innoviva
Ionis Pharmaceuticals
Lundbeck
Merck
Novo Nordisk
Otsuka
Pfizer
Roche Seagen
Seres Therapeutics
Takeda
UCB
Vertex Pharmaceuticals
CHMP gives thumbs-up for Wegovy use in adolescents, along with nine new drug recommendations
Endpoints
Sun, 04/2/23 - 04:17 pm
EMA
Europe
CHMP
Wegovy
Novo Nordisk
Bimervax
TG Therapeutics
Eli Lilly
Bristol Myers Squibb
Novartis
AstraZeneca
AstraZeneca, Amgen's asthma launch Tezspire picks up backing from England's NICE
Fierce Pharma
Wed, 03/29/23 - 09:58 am
AstraZeneca
Amgen
Tezspire
UK
NICE
asthma
severe asthma
Top 10 pharma R&D budgets in 2022
Fierce Biotech
Mon, 03/27/23 - 10:21 pm
R&D
Roche
JNJ
Merck
Pfizer
Novartis
AstraZeneca
Bristol Myers Squibb
Eli Lilly
Sanofi
AbbVie
AstraZeneca stays on course to challenge Alnylam with 66-week rare disease data
Fierce Biotech
Mon, 03/27/23 - 10:22 am
AstraZeneca
Ionis Pharmaceuticals
aplontersen
Alnylam
Onpattro
clinical trials
ATTRv-PN
Lazertinib and Tagrisso go head to head
EP Vantage
Fri, 03/24/23 - 10:01 am
AstraZeneca
lazertinib
Tagrisso
JNJ
lung cancer
AACR 2023 – Moderna's immunotherapeutic splash
EP Vantage
Wed, 03/22/23 - 10:03 am
AACR
Moderna Therapeutics
Allogene
AstraZeneca
Merck
Roche
Novartis
Eli Lilly
Innovent
Springworks
Biogene
Relay Therapeutics
Vivace Therapeutics
AstraZeneca employees fight layoffs in India as drugmaker shifts 'strategic priorities'
Fierce Pharma
Thu, 03/16/23 - 09:07 pm
AstraZeneca
layoffs
India
AstraZeneca says cancer drug Imfinzi improves survival chances in late-stage trial
Reuters
Thu, 03/9/23 - 11:40 am
AstraZeneca
Imfinzi
lung cancer
Tagrisso reaches OS endpoint in PhIII EGFR-mutated lung cancer trial
Endpoints
Thu, 03/9/23 - 10:00 am
AstraZeneca
lung cancer
clinical trials
Tagrisso
AstraZeneca draws back the curtains on its leadership team, launches new podcast
Fierce Pharma
Wed, 03/8/23 - 10:02 pm
AstraZeneca
executives
podcast
AstraZeneca, Daiichi Sankyo tease new Enhertu data — but details remain under wraps
Endpoints
Mon, 03/6/23 - 11:27 pm
AstraZeneca
Daiichi Sankyo
Enhertu
clinical trials
FDA asks advisers to review Lynparza amid growing scrutiny of PARP drugs
BioPharma Dive
Sun, 03/5/23 - 03:08 pm
Merck
AstraZeneca
Lynparza
FDA
PARP inhibitors
AstraZeneca, Merck's Lynparza to face FDA panel in prostate cancer bid as PARP scrutiny escalates
Fierce Pharma
Thu, 03/2/23 - 11:02 pm
AstraZeneca
Merck
Lynparza
FDA
prostate cancer
Go or no go? Vaccines and neurology up for discussion
EP Vantage
Tue, 02/28/23 - 11:05 am
FDA
Acadia Pharmaceuticals
Apellis Pharmaceuticals
AstraZeneca
Biogen
Biomarin
Cidara Therapeutics
Emergent BioSolutions
GSK
Incyte
Ionis Pharmaceuticals
Melinta Therapeutics
Mundipharma
Novartis
Pfizer
Pharming
Regeneron
Roche
vaccines
RSV
ALS
COVID-19
AstraZeneca expands Canada R&D work, to add 500 jobs
Endpoints
Tue, 02/28/23 - 10:01 am
AstraZeneca
Canada
hirings
R&D

Pages